Company intelligence / Profile preview

Hip Innovation Technology

Boca Raton, Florida, United Stateshipinnovationtechnology.com ↗

Ownership: Private
Development stage: Phase 1

Overview

The company's lead product, the Reverse HRS, has completed extensive bench-level testing and received FDA Investigational Device Exemption (IDE) approval to initiate a pivotal clinical study evaluating safety and effectiveness for primary total hip arthroplasty. The system aims to address common complications such as instability/dislocation and component positioning. No commercial sales yet; still under clinical investigation.

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Hip Innovation Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hip Innovation Technology.

Explore the full profile